keyword
https://read.qxmd.com/read/37149214/enhancement-of-memory-consolidation-by-an-avoidance-conditioned-stimulus-modulation-by-the-d3-receptor
#21
JOURNAL ARTICLE
Thomas Lapointe, Travis Francis, Kamrani Doray, Francesco Leri
Conditioned stimuli (CS) paired with foot-shock can enhance memory consolidation. Because the dopamine D3R has been implicated in mediating various responses to CSs, the current study explored its potential role in modulation of memory consolidation by an avoidance CS. Male Sprague-Dawley rats trained to avoid foot-shocks in a two-way signalled active avoidance task (8 sessions, 30 trials per session, 0.8 mA foot-shock) were pre-treated with the D3R antagonist NGB-2904 (Vehicle, 0.1 or 5 mg/kg) and exposed to the CS immediately after the sample phase of an object recognition memory task...
May 4, 2023: Neuropharmacology
https://read.qxmd.com/read/37002327/dutch-pharmacogenetics-working-group-dpwg-guideline-for-the-gene-drug-interaction-between-cyp2d6-cyp3a4-and-cyp1a2-and-antipsychotics
#22
JOURNAL ARTICLE
Lianne Beunk, Marga Nijenhuis, Bianca Soree, Nienke J de Boer-Veger, Anne-Marie Buunk, Henk Jan Guchelaar, Elisa J F Houwink, Arne Risselada, Gerard A P J M Rongen, Ron H N van Schaik, Jesse J Swen, Daan Touw, Roos van Westrhenen, Vera H M Deneer, Jan van der Weide
The Dutch Pharmacogenetics Working Group (DPWG) aims to facilitate pharmacogenetics implementation in clinical practice by developing evidence-based guidelines to optimize pharmacotherapy. A guideline describing the gene-drug interaction between the genes CYP2D6, CYP3A4 and CYP1A2 and antipsychotics is presented here. The DPWG identified gene-drug interactions that require therapy adjustments when respective genotype is known for CYP2D6 with aripiprazole, brexpiprazole, haloperidol, pimozide, risperidone and zuclopenthixol, and for CYP3A4 with quetiapine...
March 31, 2023: European Journal of Human Genetics: EJHG
https://read.qxmd.com/read/37000616/antimicrobial-effect-of-pimozide-by-targeting-ros-mediated-killing-in-staphylococcus-aureus
#23
JOURNAL ARTICLE
Siddhartha Kumar, Kumar Sandeep, Rakesh Kumar, Antresh Kumar
In spite of the higher nosocomial and community-acquired infections acquired by Staphylococcus aureus, emerging drug resistance is a leading cause of increased mortality and morbidity associated with the overuse of antimicrobials. It is an emergent need to find out new molecules to combat such infections. In the present study, we analyzed the antibacterial effect of pimozide (PMZ) against Gram +ve and Gram -ve bacterial strains including methicillin-sensitive (MSSA) and methicillin resistance (MRSA) S. aureus...
March 31, 2023: Biotechnology and Applied Biochemistry
https://read.qxmd.com/read/36989489/stat5-activation-promotes-progression-and-chemotherapy-resistance-in-early-t-cell-precursor-acute-lymphoblastic-leukemia
#24
JOURNAL ARTICLE
Cedric S Tremblay, Jesslyn Saw, Jacqueline A Boyle, Katharina Haigh, Veronique Litalien, Hannah Ruth McCalmont, Kathryn Evans, Richard B Lock, Stephen M Jane, Jody J Haigh, David J Curtis
IL-7 supports the growth and chemoresistance of T-cell acute lymphoblastic leukemia (T-ALL), particularly the early T-cell precursor subtype (ETP-ALL), which frequently has activating mutations of IL-7 signaling. STAT5 is an attractive therapeutic target because it is almost universally activated in ETP-ALL, even in the absence of mutations of upstream activators such as the IL-7R, JAK and FLT3. To examine the role of activated STAT5 in ETP-ALL, we have used a Lmo2-transgenic (Lmo2Tg) mouse model in which we can monitor chemoresistant pre-leukemia (pre-LSCs) and leukemia stem cells (LSCs) that drive T-ALL development and relapse following chemotherapy...
March 29, 2023: Blood
https://read.qxmd.com/read/36965286/synthesis-and-evaluation-of-99m-tc-labeled-1-2-pyridyl-piperazine-derivatives-as-radioligands-for-5ht-7-receptors
#25
JOURNAL ARTICLE
Maryam Karimi, Alireza Mardanshahi, Hamid Irannejad, Seyed Mohammad Abedi, Sajjad Molavipordanjani
Glioblastoma multiform (GBM) is one of the most aggressive tumors of the central nervous system in humans. GBM overexpresses serotonin-7 receptors (5-HT7 Rs); hence, this study aims to develop 5-HT7 R targeted radiotracers. Aryl piperazine derivatives can act as ligands for 5-HT7 R. Therefore, compounds 6 and 7 as 1-(3-nitropyridin-2-yl)piperazine derivatives were synthesized and radiolabeled with 99m TcN2+ core. Radiolabeled 6 and 7 (99m TcN-[6] and 99m TcN-[7]) were prepared with high radiochemical purity (RCP > 96%)...
March 21, 2023: Bioorganic Chemistry
https://read.qxmd.com/read/36831024/pimozide-increases-a-delayed-rectifier-k-conductance-in-chicken-embryo-vestibular-hair-cells
#26
JOURNAL ARTICLE
Roberta Giunta, Giulia Cheli, Paolo Spaiardi, Giancarlo Russo, Sergio Masetto
Pimozide is a conventional antipsychotic drug largely used in the therapy for schizophrenia and Tourette's syndrome. Pimozide is assumed to inhibit synaptic transmission at the CNS by acting as a dopaminergic D2 receptor antagonist. Moreover, pimozide has been shown to block voltage-gated Ca2+ and K+ channels in different cells. Despite its widespread clinical use, pimozide can cause several adverse effects, including extrapyramidal symptoms and cardiac arrhythmias. Dizziness and loss of balance are among the most common side effects of pimozide...
February 8, 2023: Biomedicines
https://read.qxmd.com/read/36830567/gaba-a-alpha-2-3-but-not-alpha-1-receptor-subunit-ligand-inhibits-harmaline-and-pimozide-induced-tremor-in-rats
#27
JOURNAL ARTICLE
Barbara Kosmowska, Martyna Paleczna, Dominika Biała, Justyna Kadłuczka, Jadwiga Wardas, Jeffrey M Witkin, James M Cook, Dishary Sharmin, Monika Marcinkowska, Katarzyna Z Kuter
Treatment of tremors, such as in essential tremor (ET) and Parkinson's disease (PD) is mostly ineffective. Exact tremor pathomechanisms are unknown and relevant animal models are missing. GABA-A receptor is a target for tremorolytic medications, but current non-selective drugs produce side effects and have safety liabilities. The aim of this study was a search for GABA-A subunit-specific tremorolytics using different tremor-generating mechanisms. Two selective positive allosteric modulators (PAMs) were tested...
January 18, 2023: Biomolecules
https://read.qxmd.com/read/36802832/pharmacological-interventions-for-primary-psychodermatologic-disorders-an-evidence-mapping-and-appraisal-of-randomized-controlled-trials
#28
REVIEW
Tarek Turk, Chaocheng Liu, Esther Fujiwara, Sebastian Straube, Reidar Hagtvedt, Liz Dennett, Adam Abba-Aji, Marlene Dytoc
BACKGROUND: The lack of clinical guidelines for the treatment of primary psychodermatologic disorders (PPDs) hinders the delivery of optimal care to patients. The review aimed to identify, appraise, and summarize the currently available evidence about the safety and effectiveness of pharmacological management of PPDs through randomized controlled trials (RCTs). METHODS: The Preferred Reporting Items for Systematic Review and Meta-Analyses (PRIMSA) statement and the Global Evidence Mapping Initiative guidance were followed...
2023: Journal of Cutaneous Medicine and Surgery
https://read.qxmd.com/read/36593538/multilevel-pharmacological-effects-of-antipsychotics-in-potential-glioblastoma-treatment
#29
JOURNAL ARTICLE
Wireko Andrew Awuah, Jacob Kalmanovich, Aashna Mehta, Helen Huang, Toufik Abdul-Rahman, Jyi Cheng Ng, Rohan Yarlagadda, Karl Kamanousa, Mrinmoy Kundu, Esther Patience Nansubuga, Mohammad Mehedi Hasan, Mykola Lyndin, Arda Isik, Vladyslav Sikora, Athanasios Alexiou
Glioblastoma Multiforme (GBM) is a debilitating type of brain cancer with a high mortality rate. Despite current treatment options such as surgery, radiotherapy, and the use of temozolomide and bevacizumab, it is considered incurable. Various methods, such as drug repositioning, have been used to increase the number of available treatments. Drug repositioning is the use of FDA-approved drugs to treat other diseases. This is possible because the drugs used for this purpose have polypharmacological effects. This means that these medications can bind to multiple targets, resulting in multiple mechanisms of action...
January 2, 2023: Current Topics in Medicinal Chemistry
https://read.qxmd.com/read/36552037/seventy-years-of-treating-delusional-disorder-with-antipsychotics-a-historical-perspective
#30
REVIEW
Alexandre González-Rodríguez, José A Monreal, Mentxu Natividad, Mary V Seeman
For many decades, delusional disorder (DD) has been considered a treatment-resistant disorder, with antipsychotics acknowledged as the best, though imperfect, treatment. It is possible that the discovery of the right drug could turn treatment resistance into treatment response. The goal of this narrative review is to provide a historical perspective of the treatment of DD since the introduction of antipsychotics 70 years ago. The following search terms were used to scan the literature: antipsychotics AND "delusional disorder"...
December 18, 2022: Biomedicines
https://read.qxmd.com/read/36551922/antipsychotics-in-the-treatment-of-children-and-adolescents-with-anorexia-nervosa-a-systematic-review
#31
REVIEW
Jacopo Pruccoli, Luca Bergonzini, Angela La Tempa, Antonia Parmeggiani
Evidence about the use of pharmacologic agents in the treatment of Anorexia Nervosa (AN) is lacking, especially in childhood and adolescence. A systematic scoping review was conducted to outline current literature evidence about the use of antipsychotics in this population. A total of 499 studies were identified with the initial search, and 28 of these studies were selected regarding the use of olanzapine (n = 13), risperidone (n = 4), aripiprazole (n = 3), chlorpromazine (n = 3), pimozide (n = 1) clotiapine (n = 1) and multiple antipsychotics (n = 3) in these patients...
December 7, 2022: Biomedicines
https://read.qxmd.com/read/36528030/comparative-efficacy-tolerability-and-acceptability-of-pharmacological-interventions-for-the-treatment-of-children-adolescents-and-young-adults-with-tourette-s-syndrome-a-systematic-review-and-network-meta-analysis
#32
JOURNAL ARTICLE
Luis C Farhat, Emily Behling, Angeli Landeros-Weisenberger, Jessica L S Levine, Pedro Macul Ferreira de Barros, Ziyu Wang, Michael H Bloch
BACKGROUND: In clinical practice guidelines there is no consensus about the medications that should be initially offered to children and young people with Tourette's syndrome. To provide a rigorous evidence base that could help guide decision making and guideline development, we aimed to compare the efficacy, tolerability, and acceptability of pharmacological interventions for Tourette's syndrome. METHODS: For this systematic review and network meta-analysis, we searched the Cochrane Central Register of Controlled Trials, Embase, PsycINFO, PubMed, Web of Science, the WHO International Clinical Trials Registry Platform, and ClinicalTrials...
February 2023: Lancet Child & Adolescent Health
https://read.qxmd.com/read/36442590/the-indispensable-role-of-the-rna-helicase-ddx5-in-tumorigenesis-induced-by-the-myeloproliferative-neoplasm-associated-jak2v617f-mutant
#33
JOURNAL ARTICLE
Kengo Takeda, Kenji Tago, Megumi Funakoshi-Tago
A point mutation (V617F) in the Janus kinase 2 (JAK2) gene results in the production of disorderly activated tyrosine kinase, which causes myeloproliferative neoplasms (MPN). We herein demonstrated that the RNA helicase DDX5 was highly expressed at the mRNA and protein levels through the activation of signal transducer and activator of transcription 5 (STAT5) in Ba/F3 cells expressing a JAK2V617F mutant and erythropoietin receptor (V617F/EpoR cells) and MPN patient-derived HEL cells. A treatment with the JAK1/2 inhibitor, ruxolitinib and STAT5 inhibitor, pimozide significantly inhibited DDX5 mRNA expression and enhanced the degradation of DDX5 in these cells, suggesting that the JAK2V617F mutant positively regulates DDX5 mRNA expression and DDX5 protein stability by activating STAT5...
November 25, 2022: Cellular Signalling
https://read.qxmd.com/read/36352191/inhibition-of-usp1-reverses-the-chemotherapy-resistance-through-destabilization-of-max-in-the-relapsed-refractory-b-cell-lymphoma
#34
JOURNAL ARTICLE
Xi-Ya Li, Ji-Chuan Wu, Ping Liu, Zi-Juan Li, Yong Wang, Bing-Yi Chen, Cheng-Long Hu, Ming-Yue Fei, Peng-Cheng Yu, Yi-Lun Jiang, Chun-Hui Xu, Bin-He Chang, Xin-Chi Chen, Li-Juan Zong, Jia-Ying Zhang, Ying Fang, Xiao-Jian Sun, Kai Xue, Li Wang, Shu-Bei Chen, Shi-Yu Jiang, Ai-Ling Gui, Ling Yang, Juan J Gu, Bao-Hua Yu, Qun-Ling Zhang, Lan Wang
The patients with relapsed and refractory diffuse large B-cell lymphoma (DLBCL) have poor prognosis, and a novel and effective therapeutic strategy for these patients is urgently needed. Although ubiquitin-specific protease 1 (USP1) plays a key role in cancer, the carcinogenic effect of USP1 in B-cell lymphoma remains elusive. Here we found that USP1 is highly expressed in DLBCL patients, and high expression of USP1 predicts poor prognosis. Knocking down USP1 or a specific inhibitor of USP1, pimozide, induced cell growth inhibition, cell cycle arrest and autophagy in DLBCL cells...
January 2023: Leukemia
https://read.qxmd.com/read/36256885/the-antipsychotic-dopamine-2-receptor-antagonist-diphenylbutylpiperidines-improve-glycemia-in-experimental-obesity-by-inhibiting-succinyl-coa-3-ketoacid-coa-transferase
#35
JOURNAL ARTICLE
Seyed Amirhossein Tabatabaei Dakhili, Amanda A Greenwell, Kunyan Yang, Rabih Abou Farraj, Christina T Saed, Keshav Gopal, Jordan S F Chan, Jadin J Chahade, Farah Eaton, Crystal Lee, Carlos A Velazquez-Martinez, Peter A Crawford, J N Mark Glover, Rami Al Batran, John R Ussher
Despite significant progress in understanding the pathogenesis of type 2 diabetes (T2D), it remains difficult to manage. Hence, new therapeutic options targeting unique mechanisms of action are required. We have previously observed that elevated skeletal muscle succinyl CoA:3-ketoacid CoA transferase (SCOT) activity, the rate-limiting enzyme of ketone oxidation, contributes to the hyperglycemia characterizing obesity and T2D. Moreover, we identified that the typical antipsychotic agent, pimozide, is a SCOT inhibitor that can alleviate obesity-induced hyperglycemia...
October 18, 2022: Diabetes
https://read.qxmd.com/read/36181876/p-glycoprotein-mediated-pharmacokinetic-interactions-increase-pimozide-herg-channel-inhibition
#36
JOURNAL ARTICLE
Hiroki Morishita, Liyanage Manosika Buddhini Perera, Xieyi Zhang, Kenta Mizoi, Masa-Aki Ito, Kentaro Yano, Takuo Ogihara
Pimozide, an antipsychotic drug, is a potent inhibitor of the hERG channel. A case of death due to cardiac arrest has been reported in a boy who received pimozide together with sertraline and aripiprazole. In this study, we focused on drug-drug interactions and investigated the relationships between transporter-mediated intracellular accumulation and the hERG inhibitory effect of pimozide. The accumulation of pimozide in cardiomyocyte-derived AC16 cells was significantly increased by sertraline and aripiprazole, which are thought to have a P-glycoprotein (P-gp) inhibitory effect, and under P-gp siRNA conditions...
September 28, 2022: Journal of Pharmaceutical Sciences
https://read.qxmd.com/read/36153316/inhibition-of-usp1-enhances-anticancer-drugs-induced-cancer-cell-death-through-downregulation-of-survivin-and-mir-216a-5p-mediated-upregulation-of-dr5
#37
JOURNAL ARTICLE
Seon Min Woo, Seok Kim, Seung Un Seo, Shin Kim, Jong-Wook Park, Gyeonghwa Kim, Yu-Ra Choi, Keun Hur, Taeg Kyu Kwon
Ubiquitin-specific protease 1 (USP1) is a deubiquitinase involved in DNA damage repair by modulating the ubiquitination of major regulators, such as PCNA and FANCD2. Because USP1 is highly expressed in many cancers, dysregulation of USP1 contributes to cancer therapy. However, the role of USP1 and the mechanisms underlying chemotherapy remain unclear. In this study, we found high USP1 expression in tumor tissues and that it correlated with poor prognosis in RCC. Mechanistically, USP1 enhanced survivin stabilization by removing ubiquitin...
September 24, 2022: Cell Death & Disease
https://read.qxmd.com/read/36150062/targeting-stat5-signaling-overcomes-resistance-to-idh-inhibitors-in-acute-myeloid-leukemia-through-suppression-of-stemness
#38
JOURNAL ARTICLE
Alex C H Liu, Severine Cathelin, Yitong Yang, David L Dai, Dhanoop Manikoth Ayyathan, Mohsen Hosseini, Mark D Minden, Anne Tierens, Steven M Chan
Mutant isocitrate dehydrogenase 1 (IDH1) and IDH2 block the differentiation of acute myeloid leukemia (AML) cells through production of R-2-hydroxyglutarate (R-2-HG). IDH inhibitors can induce differentiation of AML cells by lowering R-2-HG but have limited clinical efficacy as single agents. Here, we performed a genome-wide CRISPR knockout screen in an Idh1-mutated hematopoietic progenitor cell line to identify genes that increased the differentiation response to ivosidenib, an IDH1 inhibitor. The screen identified C-type lectin member 5a (Clec5a), which encodes a spleen tyrosine kinase (SYK)-coupled surface receptor, as one of the top hits...
September 23, 2022: Cancer Research
https://read.qxmd.com/read/36075145/discovery-of-pimozide-derivatives-as-novel-t-type-calcium-channel-inhibitors-with-little-binding-affinity-to-dopamine-d-2-receptors-for-treatment-of-somatic-and-visceral-pain
#39
JOURNAL ARTICLE
Yoshihito Kasanami, Chihiro Ishikawa, Takahiro Kino, Momoka Chonan, Naoki Toyooka, Yasuhiro Takashima, Yuriko Iba, Fumiko Sekiguchi, Maho Tsubota, Tsuyako Ohkubo, Shigeru Yoshida, Atsushi Kawase, Takuya Okada, Atsufumi Kawabata
T-type Ca2+ channels (T-channels), particularly Cav 3.2 and Cav 3.1 isoforms, are promising targets for treating various diseases including intractable pain. Given the potent inhibitory activity of pimozide, an antipsychotic, against T-channels, we conducted structure-activity relationship studies of pimozide derivatives, and identified several compounds including 3a, 3s, and 4 that had potency comparable to that of pimozide in inhibiting T-channels, but little binding affinity to dopamine D2 receptors. The introduction of a phenylbutyl group on the benzoimidazole nuclei of pimozide was considered a key structural modification to reduce the binding affinity to D2 receptors...
December 5, 2022: European Journal of Medicinal Chemistry
https://read.qxmd.com/read/35930306/molecular-dynamics-and-docking-studies-on-potentially-active-natural-phytochemicals-for-targeting-sars-cov-2-main-protease
#40
JOURNAL ARTICLE
Sandhya Karakkadparambil Sankaran, Achuthsankar S Nair
In the present study, we screened eighty seven novel phytochemical compounds from four popular herbs, such as, Aegle Marmelos, Coleus Amboinicus, Aerva Lanata and Biophytum Sensitivum and identified the best three for targeting the main protease (Mpro ) receptor of SARS-CoV-2. After categorizing all the phytochemicals based upon LibDock scores and hydrogen bonding interactions, the top ranked 26 compounds were further subjected for detailed Molecular dynamics (MD) study. From these screening we identified that Aegelinosides B leads the list with a high LibDock value of 142...
August 5, 2022: Journal of Biomolecular Structure & Dynamics
keyword
keyword
108379
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.